OrbiMed

Alternative investment giant KKR played an active role in the deals we tracked today, striking the ...

Medical devices, biotechnology and medtech platforms accounted for most of the private equity and VC investment ...

AW Research tracked about $2 billion in private market deals across credit, equity and real estate ...

AW Research tracked about $2.3 billion in private market deals across credit, equity, infrastructure and real ...

AW Research tracked about $15.5 billion in private market deals across credit, equity, infrastructure and real estate ...

Divided by asset class, Alternatives Watch tracked a total of roughly $2.1 billion in deals publicly announced in ...

Divided by asset class, Alternatives Watch tracked about $4.4 billion in alternative investment deals announced in the week ...

Divided by asset class, Alternatives Watch tracked a total of roughly $9.4 billion in deals publicly announced in ...

J.P. Morgan launched its new life sciences private equity team -- Life Sciences Private Capital -- ...

Divided by asset class, Alternatives Watch tracked a total of roughly $14.6 billion in deals publicly announced in ...